Grow House Wealth Management Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of the Sarda Proteins Ltd ("Target Company").
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 04 Jun 2026, 02:17 PM IST · BSE ID: 0af4e606-0ecd-49ff-9f20-fa14c57a7fdd
View Original BSE Filing (PDF)
💡
In Simple Terms
The formal offer document has been issued for Onix Renewable Limited to buy 19.28% of Sarda Proteins Ltd. shares for ₹ 115.00 each.
🤖 AI Summary
- Letter of Offer submitted for open offer to acquire 17,30,400 equity shares of Sarda Proteins Ltd.
- Onix Renewable Limited, along with three PACs, is the acquirer in this open offer.
- The offer price for Sarda Proteins Ltd. shares is set at ₹ 115.00 per equity share.
- The acquisition represents 19.28% of the emerging voting share capital of the target company.
- The offer is compliant with Regulations 3(1) & 4 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Offered
17,30,400
Offer Price Per Equity Share
₹ 115.00
Percentage of Emerging Voting Share Capital
19.28%
Face Value Per Equity Share
₹ 10.00/-
🏢 How This Affects the Company
The ongoing open offer process introduces uncertainty regarding the future ownership and strategic direction of Sarda Proteins Ltd. until completion.
👥 What This Means For Shareholders
✅
Action Required
Shareholders wishing to tender their shares must review the Letter of Offer and submit the accompanying Form of Acceptance cum acknowledgement and Transfer Deed.
👤
Who Is Affected
Public shareholders of Sarda Proteins Ltd. holding 17,30,400 equity shares or less are affected, as the offer is for 19.28% of the emerging voting share capital at ₹ 115.00 per share.
🔍
Management Signal
The offer signals an intent by Onix Renewable Limited and PACs to gain substantial acquisition of shares and control of Sarda Proteins Ltd., as outlined by SEBI (SAST) Regulations.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Tendering period commencement and end dates for the open offer.
Confirmation of final number of shares tendered in the open offer.
Any revisions to the offer price or size before the tendering period.
MEDIUM RISK
The open offer process inherently involves risks related to its completion and potential changes in company control.
💡 Investor Takeaway
The Letter of Offer for Sarda Proteins Ltd.'s open offer is now public, detailing Onix Renewable Limited and PACs' intent to acquire 17,30,400 equity shares at ₹ 115.00 per share, representing 19.28% of the voting share capital.
⚖️ Strengths & Concerns
✅ Positives
- The offer provides public shareholders an exit opportunity for 17,30,400 shares at a specific price of ₹ 115.00 per equity share.
⚠️ Concerns
- The offer size is restricted to 19.28% of emerging voting share capital, below the 26% typically expected under SEBI (SAST) Regulations.
📅 Company Track Record
Previous filing on April 8, 2026, disclosed the formal initiation of the Sarda Proteins Ltd. acquisition process via a Draft Letter of Offer, managed by Grow House Wealth Management Pvt Ltd.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the offer price for Sarda Proteins Ltd. shares in the open offer?
The offer price for Sarda Proteins Ltd. equity shares is ₹ 115.00 (Rupees One Hundred Fifteen Only) per fully paid-up Equity Share.
How many shares are being sought in the open offer for Sarda Proteins Ltd.?
The open offer is for the acquisition of 17,30,400 (Seventeen Lakhs Thirty Thousand Four Hundred) equity shares of Sarda Proteins Ltd.
What percentage of Sarda Proteins Ltd.'s voting share capital does this open offer represent?
The open offer represents 19.28% (Nineteen point Two Eight percent) of the Emerging Voting Share Capital of Sarda Proteins Ltd.
Who is the acquirer in the open offer for Sarda Proteins Ltd.?
Onix Renewable Limited, along with PACs (Divyeshkumar Mansukhbhai Savaliya, Piyush Mansukhbhai Savaliya, Nikhil Hareshbhai Savaliya), is the acquirer in the open offer.
Questions based on this BSE filing only. For information purposes.